https://orcid.org/0000-0002-2786-156X
Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Mohammad Mehdi Naghizadeh, Behnaz Bakhshandeh, Farshid Noorbakhsh, Marjan Yaghmaie & Ali Masoudi-Nejad. (2023) Rewiring of miRNA-mRNA bipartite co-expression network as a novel way to understand the prostate cancer related players. Systems Biology in Reproductive Medicine 69:4, pages 320-331.
Read now
Read now
Chundong Liu & Rui Xu. (2022) Dexmedetomidine protects H9C2 rat cardiomyocytes against hypoxia/reoxygenation injury by regulating the long non-coding RNA colon cancer-associated transcript 1/microRNA-8063/Wnt/β-catenin axis. Bioengineered 13:5, pages 13300-13311.
Read now
Read now
Yue Zhang, Yue Yu, Xuchen Cao & Peng Chen. (2022) Role of lncRNA FAM83H antisense RNA1 (FAM83H-AS1) in the progression of non-small cell lung cancer by regulating the miR-545-3p/heparan sulfate 6-O-sulfotransferase (HS6ST2) axis. Bioengineered 13:3, pages 6476-6489.
Read now
Read now
Chao Sun, Cuicui Shi, Xiaoyan Duan, Yi Zhang & Baocan Wang. (2022) Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting Smad4. Bioengineered 13:3, pages 5915-5927.
Read now
Read now
Jiawei Yan & Hongyan Xu. (2021) Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma. Bioengineered 12:2, pages 12420-12430.
Read now
Read now
Jinpeng Chen, Lin Liao, Huiyong Xu, Zheng Zhang & Jian Zhang. (2021) Long non-coding RNA MEG3 inhibits neovascularization in diabetic retinopathy by regulating microRNA miR-6720-5p and cytochrome B5 reductase 2. Bioengineered 12:2, pages 11872-11884.
Read now
Read now
Zhongzhi Jin & Shengjun Jiang. (2021) Long non-coding RNA TTN-AS1/microRNA-199a-3p/runt-related transcription factor 1 gene axis regulates the progression of oral squamous cell carcinoma. Bioengineered 12:1, pages 7724-7736.
Read now
Read now
Conggang Huang, Lan Ma, Faliang Duan, Ruixue Li, Yanguo Zhang, Yuan Wang, Ming Luo, Zhuqiang He & Zhihua Luo. (2021) MicroRNA-485-5p inhibits glioblastoma progression by suppressing E2F transcription factor 1 under cisplatin treatment. Bioengineered 12:1, pages 8020-8030.
Read now
Read now
Xiaobin Chi, Yi Jiang, Yongbiao Chen, Lizhi Lv, Jianwei Chen, Fang Yang, Xiaojin Zhang, Fan Pan & Qiucheng Cai. (2021) Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion. Bioengineered 12:1, pages 7519-7528.
Read now
Read now
Lin Sun, Yan Wei & Junli Wang. (2021) Circular RNA PIP5K1A (circPIP5K1A) accelerates endometriosis progression by regulating the miR-153-3p/Thymosin Beta-4 X-Linked (TMSB4X) pathway. Bioengineered 12:1, pages 7093-7107.
Read now
Read now
Yi Luo, Xiu Qu, Dan Kan & Binlin Cai. (2021) The microRNA-451a/chromosome segregation 1-like axis suppresses cell proliferation, migration, and invasion and induces apoptosis in nasopharyngeal carcinoma. Bioengineered 12:1, pages 6967-6980.
Read now
Read now
Feng Shi, Luquan Zhang, Xing Liu & Yue Wang. (2021) Knock-down of microRNA miR-556-5p increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via activating NLR family pyrin domain containing 3 (NLRP3)-mediated pyroptotic cell death. Bioengineered 12:1, pages 6332-6342.
Read now
Read now
Yue Yang, Longqing Shi, Dong Zhang, Di Wu, Yong an, Yue Zhang & Xuemin Chen. (2021) Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1). Bioengineered 12:1, pages 6713-6723.
Read now
Read now
Jinming Yu, Yongmei Li, Deguo Leng, Cheng Cao, Yongzhi Yu & Yijuan Wang. (2021) microRNA-3646 serves as a diagnostic marker and mediates the inflammatory response induced by acute coronary syndrome. Bioengineered 12:1, pages 5632-5640.
Read now
Read now
Dan Liu, Lang Wan, Hao Gong, Shiming Chen, Yonggang Kong & Bokui Xiao. (2021) Sevoflurane promotes the apoptosis of laryngeal squamous cell carcinoma in-vitro and inhibits its malignant progression via miR-26a/FOXO1 axis. Bioengineered 12:1, pages 6364-6376.
Read now
Read now
Lei Jiang, Wenyu Ge, Yifei Cui & Xiaofeng Wang. (2021) The regulation of long non-coding RNA 00958 (LINC00958) for oral squamous cell carcinoma (OSCC) cells death through absent in melanoma 2 (AIM2) depending on microRNA-4306 and Sirtuin1 (SIRT1) in vitro. Bioengineered 12:1, pages 5085-5098.
Read now
Read now
Zhen Li, Congjian Xu & Di Sun. (2021) MicroRNA-488 serves as a diagnostic marker for atherosclerosis and regulates the biological behavior of vascular smooth muscle cells. Bioengineered 12:1, pages 4092-4099.
Read now
Read now
Jing Han, Hua Tang, Longfei Yao, Erliang Jin, Wanxi Pan & Shaojun Chen. (2021) Azilsartan protects against hyperglycemia-induced hyperpermeability of the blood-brain barrier. Bioengineered 12:1, pages 3621-3633.
Read now
Read now
He-Wei Zhang, Ying Guo, Lin-xiao Sun, Fu-biao Ni & Ke Xu. (2021) Prognostic value of small mother against decapentaplegic expression in human gastric cancer. Bioengineered 12:1, pages 2534-2549.
Read now
Read now
Lishan Wang, Shuqing Ge & Futing Zhou. (2021) MicroRNA-487a-3p inhibits the growth and invasiveness of oral squamous cell carcinoma by targeting PPM1A. Bioengineered 12:1, pages 937-947.
Read now
Read now
Jing Zhao, Kai Zhou, Liang Ma & Huanyu Zhang. (2020) MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis in vitro and in vivo. Bioengineered 11:1, pages 219-228.
Read now
Read now
Articles from other publishers (24)
Pratikshya Sa, Priya Singh, Sudhakar Panda, Rajeeb K. Swain, Rupesh Dash & Sanjeeb Kumar Sahoo. (2024) Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway. Translational Research 268, pages 63-78.
Crossref
Crossref
Yangyang Yin, Yuqi Yang, Yongqiang Zhang, Yu Shang, Qian Li & Jing Yuan. (2024) MiR-132-3p suppresses peritoneal fibrosis induced by peritoneal dialysis via targeting TGF-β1/Smad2/3 signaling pathway. PLOS ONE 19:4, pages e0301540.
Crossref
Crossref
Amir Oliyaierezaie, Habib Zarredar, Milad Asadi, Venus Zafari, Dariush Shanebandi, Zahra Soleimani, Mohammad-Reza Firoozi & Shahram Ghasembaglou. (2023) Evaluation of Potential miR-302, miR-132, miR-205, and miR-126 as Biomarkers for Laryngeal Squamous Cell Carcinoma. International Journal of Cancer Management 16:1.
Crossref
Crossref
Asrarunissa Kalmatte, Punchappady Devasya Rekha & Chandrahas Koumar Ratnacaram. (2023) Emerging cell cycle related non-coding RNA biomarkers from saliva and blood for oral squamous cell carcinoma. Molecular Biology Reports 50:11, pages 9479-9496.
Crossref
Crossref
Meghdad Eslami, Saba Khazeni, Xaniar Mohammadi Khanaghah, Mohammad Hossein Asadi, Mohamad Amin Ansari, Javad Hayati Garjan, Mohammad Hassan Lotfalizadeh, Mobina Bayat, Mohammad Taghizadieh, Seyed Pouya Taghavi, Michael R Hamblin & Javid Sadri Nahand. (2023) MiRNA-related metastasis in oral cancer: moving and shaking. Cancer Cell International 23:1.
Crossref
Crossref
Faezeh Tolue Ghasaban, Amirhosein Maharati, Amir Sadra Zangouei, Alireza Zangooie & Meysam Moghbeli. (2023) MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers. Cancer Cell International 23:1.
Crossref
Crossref
Saurabh Dey, Bini Biswas, Angela Manoj Appadan, Jaladhi Shah, Jayanta Pal, Soumya Basu & Subhayan Sur. (2023) Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications. Cancers 15:15, pages 3752.
Crossref
Crossref
Yupeng Chen, Lin Wu & Min Bao. (2022) MiR-485-5p Suppress the Malignant Characteristics of the Lung Adenocarcinoma via Targeting NADPH Quinone Oxidoreductase-1 to Inhibit the PI3K/Akt. Molecular Biotechnology 65:5, pages 794-806.
Crossref
Crossref
Xue Hu, Jie Li, Yuhao Zhang, Menghua Xiong, Houbing Zhang & Youyong Yuan. (2023) A helical oncolytic polypeptide with potent membranolytic activity for cancer therapy. Biomaterials Science 11:4, pages 1451-1458.
Crossref
Crossref
Long Xing, Zhenghu Feng, Hongbing Nie, Meitian Liu, Yali Liu, Xiaohua Zhang & Haijing Zhou. (2022) Research progress and clinical application prospects of miRNAs in oral cancer. Molecular Biology Reports 49:11, pages 10653-10665.
Crossref
Crossref
Yuliannis Lugones, Pía Loren & Luis A. Salazar. (2022) Cisplatin Resistance: Genetic and Epigenetic Factors Involved. Biomolecules 12:10, pages 1365.
Crossref
Crossref
Jana Maslankova, Ivana Vecurkovska, Miroslava Rabajdova, Jana Katuchova, Milos Kicka, Michala Gayova & Vladimir Katuch. (2022) Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer. World Journal of Gastroenterology 28:33, pages 4744-4761.
Crossref
Crossref
Chuansheng Yang, Zhikai Mai, Can Liu, Shuanghong Yin, Yantao Cai & Chenglai Xia. (2022) Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways. Molecules 27:11, pages 3513.
Crossref
Crossref
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Yalda Saghari, Ali Zarrabi, Michael R. Hamblin, Maliheh Entezari, Mehrdad Hashemi, Amir Reza Aref, Kiavash Hushmandi, Alan Prem Kumar, Navid Rabiee, Milad Ashrafizadeh & Saeed Samarghandian. (2022) Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?. International Journal of Biological Macromolecules 206, pages 435-452.
Crossref
Crossref
Mahmood K. Mahabady, Sepideh Mirzaei, Hamidreza Saebfar, Mohammad H. Gholami, Amirhossein Zabolian, Kiavash Hushmandi, Farid Hashemi, Fatemeh Tajik, Mehrdad Hashemi, Alan P. Kumar, Amir R. Aref, Ali Zarrabi, Haroon Khan, Michael R. Hamblin, Yavuz Nuri Ertas & Saeed Samarghandian. (2022) Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity. Journal of Cellular Physiology 237:5, pages 2309-2344.
Crossref
Crossref
Andras Tomesz, Laszlo Szabo, Richard Molnar, Arpad Deutsch, Richard Darago, Bence L. Raposa, Nowrasteh Ghodratollah, Timea Varjas, Balazs Nemeth, Zsuzsanna Orsos, Eva Pozsgai, Jozsef L. Szentpeteri, Ferenc Budan & Istvan Kiss. (2022) Changes in miR-124-1, miR-212, miR-132, miR-134, and miR-155 Expression Patterns after 7,12-Dimethylbenz(a)anthracene Treatment in CBA/Ca Mice. Cells 11:6, pages 1020.
Crossref
Crossref
Chaofan Gong, Rohit Bhargava & Chandrajit Bajaj. (2022) Exploring the Study of miR-1301 Inhibiting the Proliferation and Migration of Squamous Cell Carcinoma YD-38 Cells through PI3K/AKT Pathway under Deep Learning Medical Images. Computational Intelligence and Neuroscience 2022, pages 1-10.
Crossref
Crossref
Muhammad T. Abdel Ghafar & Nema A. Soliman. 2022.
235
280
.
Mohammad Taheri, Hamed Shoorei, Farhad Tondro Anamag, Soudeh Ghafouri-Fard & Marcel E. Dinger. (2021) LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin. Experimental and Molecular Pathology 123, pages 104602.
Crossref
Crossref
Priya Mondal & Syed Musthapa Meeran. (2021) microRNAs in cancer chemoresistance: The sword and the shield. Non-coding RNA Research 6:4, pages 200-210.
Crossref
Crossref
Maoduo Zhang, Ying Yi Zhang, Yongze Chen, Jia Wang, Qiang Wang & Hezhe Lu. (2021) TGF-β Signaling and Resistance to Cancer Therapy. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Yali Cheng, Shaoming Li, Ling Gao, Keqian Zhi & Wenhao Ren. (2021) The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Meysam Moghbeli, Amir Sadra Zangouei, Zahra Nasrpour Navaii & Negin Taghehchian. (2021) Molecular mechanisms of the microRNA-132 during tumor progressions. Cancer Cell International 21:1.
Crossref
Crossref
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Mahshad Kalantari, Reza Mohammadinejad, Tahereh Javaheri & Gautam Sethi. (2020) Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance. International Journal of Molecular Sciences 21:11, pages 4002.
Crossref
Crossref